SCHEMBL24512696

SCHEMBL24512696

O=Cc1cc(Oc2ccc(F)cc2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.41
▸ SCN9A Q15858 2/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ SOS1 Q07889 1/20 0.39
▸ HSPB1 P04792 1/20 0.39
▸ TRPA1 O75762 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ SCN4A P35499 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ S1PR2 O95136 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12519534 0.83 ALDH1A1 (0.47) ALDH1A1CYP3A4KDM4ELMNASMN1; SMN2
SCHEMBL14050309 0.81 NR4A1 (0.38) ALDH1A1L3MBTL1SCN9AKCNH2SCN5A
SCHEMBL16838775 0.76 L3MBTL1 (0.53) ALDH1A1L3MBTL1HRH3SCN9AKCNH2
SCHEMBL24512716 0.75 L3MBTL1 (0.51) ALDH1A1L3MBTL1SCN9AKCNH2SCN5A
SCHEMBL11999814 0.74 — —
SCHEMBL1415532 0.74 S1PR2 (0.46) L3MBTL1HRH3SCN9AKCNH2SCN5A
SCHEMBL17356164 0.73 CCR1 (0.32) ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL1208300 0.73 CCR1 (0.55) ALDH1A1KDM4ELMNAMAPT
SCHEMBL29601133 0.73 CCR1 (0.55) ALDH1A1KDM4ELMNAMAPT
SCHEMBL28322344 0.72 GPR3 (0.37) SCN9ASCN5ACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 ALDH1A1 2761/4885L3MBTL1 3807/4885HRH3 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback